Inoue Masashi, Kako Eisuke, Kinugasa Rie, Sano Fumiaki, Iguchi Hironobu, Sobue Kazuya
Department of Anesthesiology and Intensive Care Medicine, Nagoya City University Graduate School of Medical Sciences, 1-Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, 467-8601, Japan.
JA Clin Rep. 2019 Apr 27;5(1):29. doi: 10.1186/s40981-019-0249-7.
Primary peritonitis due to Streptococcus pyogenes (S. pyogenes) is uncommon in patients without comorbid conditions such as immunosuppression, nephritic disease, or liver cirrhosis. Furthermore, it does not cause another infection at the same time in a healthy person. However, several S. pyogenes mutants have been reported, and some of them exhibit strong virulence. Mutation of the control of virulence (cov) S gene of Streptococcus enhances bacterium survival by repressing negative regulators of virulence, which causes bacterial invasion of aseptic tissues, such as the parenteral space. We report a case of primary peritonitis and subsequent necrotizing fasciitis by the same S. pyogenes species with mutated covS in a previously healthy woman.
We present the case of a 55-year-old woman admitted to the hospital due to abdominal pain and nausea. She was treated for peritonitis. A few days later, she became hypotensive and tachycardic and was transferred to the intensive care unit (ICU) for the treatment of septic shock with primary peritonitis. On the second day of her ICU stay, both of her forearms developed swelling and redness around the peripheral injection site. The patient had developed necrotizing fasciitis. Since her skin symptoms spread rapidly, urgent debridement was performed. Her condition improved with antibiotic treatment and multiple episodes of debridement. S. pyogenes was detected in cultures of the patient's blood, ascites, and skin. The identified strain was emm89 genotype and had a genetic mutation of covS.
S. pyogenes with covS mutation may spread from a portal, such as the upper respiratory tract or digestive system, to all organs immediately, causing septic shock. Infection with S. pyogenes with mutated genes should be considered in the differential diagnosis of gastrointestinal symptoms, even in a previously healthy patient.
在没有免疫抑制、肾病或肝硬化等合并症的患者中,由化脓性链球菌(S. pyogenes)引起的原发性腹膜炎并不常见。此外,它不会在健康人身上同时引发另一种感染。然而,已有数种化脓性链球菌突变体被报道,其中一些表现出很强的毒力。化脓性链球菌毒力控制(cov)S基因的突变通过抑制毒力负调控因子来提高细菌的存活率,从而导致细菌侵入无菌组织,如体腔。我们报告了一例先前健康的女性患者,由同一株covS基因发生突变的化脓性链球菌引起原发性腹膜炎及随后的坏死性筋膜炎的病例。
我们呈现了一名55岁女性因腹痛和恶心入院的病例。她接受了腹膜炎治疗。几天后,她出现低血压和心动过速,并被转至重症监护病房(ICU)治疗原发性腹膜炎伴感染性休克。在她入住ICU的第二天,她的双前臂外周注射部位周围出现肿胀和发红。患者患上了坏死性筋膜炎。由于她的皮肤症状迅速蔓延,遂进行了紧急清创术。经过抗生素治疗和多次清创,她的病情有所改善。在患者的血液、腹水和皮肤培养物中检测到了化脓性链球菌。鉴定出的菌株为emm89基因型,且covS基因发生了突变。
covS基因发生突变的化脓性链球菌可能会立即从诸如上呼吸道或消化系统等门户扩散至所有器官,导致感染性休克。即使是先前健康的患者,在对胃肠道症状进行鉴别诊断时也应考虑感染了基因发生突变的化脓性链球菌。